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Abstract
Background: Lung cancer is usually presented with cough, dyspnea, pain and weight loss, which is overlapping
with symptoms of other lung diseases such as pulmonary fibrosis. Pulmonary fibrosis shows characteristic reticular
and nodular pattern, while lung cancers are mostly presented with infiltrative mass, thick-walled cavitations or a
solitary nodule with spiculated borders. If the diagnosis is established based on clinical symptoms and CT findings,
it would be a misapprehension.
Case presentation: We report a case of lung adenocarcinoma whose symptoms as well as clinical images
overlapped strongly with pulmonary fibrosis. The patient’s non-productive cough, progressive dyspnea, restrictive
pattern of pulmonary function test and CT scans (showing reticular interstitial opacities) were all indicative of
pulmonary fibrosis. The patient underwent a treatment consisting of corticosteroids and antibiotics, to no avail.
Histopathology of the lung showed that the patient suffered from mucinous adenocarcinoma. Albeit the
immunohistochemical staining was not consistent with lung adenocarcinoma, tumor’s morphological characteristics
were consistent, and were used to make the definitive diagnosis.
Conclusion: Given the fact that radiography cannot always make a clear-cut difference between pulmonary fibrosis
and lung adenocarcinomas, and that clinical symptoms often overlap, histological examination should be
considered as gold standard for diagnosis of lung adenocarcinoma.
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Background
Adenocarcinoma of the lung is the most common type
of lung cancer, accounting for approximately one half of
all lung cancer cases. The increased incidence of adeno-
carcinoma is thought to be due to the introduction of
low-tar filter cigarettes in the 1960s, although this caus-
ality has never been confirmed [1]. Histological diagnosis
requires evidence of either neoplastic gland formation or
intracytoplasmic mucin. There are significant variations
in the extent and architecture of neoplastic gland forma-
tion, ranging from well-formed acini to more papillary
and even cribriform types [2]. Lung adenocarcinoma,
especially types with lepidic growth pattern, can have
highly variable clinical presentation, and range from a
small solitary nodule or limited number of nodules, to
more extensive miliary disease, or diffuse parenchymal
infiltrates that are similar in appearance to bacterial
pneumonia [3, 4] Because of these characteristics, it’s
often called “masquerader“ [3, 5]. The exact mechanism
of lung adenocarcinoma pathogenesis is still being inves-
tigated, however it appears that tumor proliferation is
eclipsed by noticeable inflammation and fibrosis that
mimic a benign inflammation [5], thus confusing
physicians and consequently delaying diagnosis, as
well as affecting quality of patients’ life. Traditionally,
classification of lung carcinoma has been based solely
on evaluation of routinely stained biopsies or cyto-
logical smears. However, ancillary tests such as immu-
nohistochemistry are being increasingly used to aid
pathologists in diagnosis of subtypes. Lung adenocar-
cinoma shows specific staining patterns, which are
useful in the differential diagnosis of poorly differenti-
ated neoplasms. The following patterns are positive:
TTF-1, napsin A, CK 7, mucicarmine, PAS-D [6, 7].
In 2011, a multidisciplinary expert panel representing
the International Association for the Study of Lung
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Cancer (IASLC), the American Thoracic Society
(ATS), and the European Respiratory Society (ERS)
proposed a major revision of the classification system.
These changes primarily affect the classification of
adenocarcinoma and its distinction from squamous
cell carcinoma. The 2011 IASLC/ATS/ERS classifica-
tion of lung adenocarcinoma schema stresses the im-
portance of radiographic findings in this approach to
classification of lung adenocarcinoma [8].
Here we report a case of lung adenocarcinoma that
mimicked pulmonary fibrosis, as based on the clinical
symptoms and radiographic images. Also, in this case
the diagnosis of mucinous adenocarcinoma of pulmon-
ary origin was determined based on histological type,
despite the unusual immunohistochemical pattern for
this type of lung cancer.
Case presentation
A 59 year-old woman, smoker 22 pac/year, presented
to hospital with 4 months of worsening dyspnea, non-
productive cough at first, but lately she was able to
cough up a thick, white sputum. She has lost 5 k
since the beginning of the disease. She denied having
hemoptisis and systemic infection symptoms, such as
fever, chills and sweats. The patient’ had been regu-
larly taking therapy for high blood pressure for
10 years. Pulmonary examination showed notably
descended and immovable hemidiaphragms with de-
creased breath sounds accompanied by some low-
pitched whistles. Lung function testing registered
medium level restrictive disturbances of ventilatory
insufficiency. DLCO was 27 %. Gas analysis of arterial
blood registered hypoxic respiratory failure (PaO2
7.14 PaCO2 4.61 pH 3.37 SaO2 83 %). Chest X-ray
demonstrated bilateral reticular opacities with honey-
combing with predominant sub pleural distribution.
CT confirmed findings of reticular interstitial opacities
with extended and deformed small airways filled with
plenty of thick mucus, visible bronchiectasis and
thickening of interlobular septa (Figs. 1 and 2). Bron-
choscope findings were unremarkable with a lot of
mucus gushing from the segmental bronchi. Histo-
pathological finding of transbronchial biopsy as well
as cytological examinations of bronchoaspirate was
not conclusive. Progressive course of the disease with-
out response to antibiotics and corticosteroid therapy
indicated underlying malignant disease.
Consequently the patient underwent video-assisted
thoracoscopy with lung biopsy under general anesthesia.
Tissue histology revealed mucinous adenocarcinoma
of the lung with pleural infiltration (stage PL1); pat-
tern was largely lepidic with smaller foci of acinar
growth (Figs. 3 and 4), partially thickened septa and
several cuts presented expanded air pathway that
creates the image of centriacinar emphysema. Immu-
nohistochemical finding was TTF1 negative, napsin
negative, CDX2 negative, CK7 positive, and CK20
negative. In addition, approximately 20 % of lung
adenocarcinomas are TTF1 negative, which further
complicates the diagnosis [8–10]. Despite the fact that
immunohistochemical staining wasn’t specific for mu-
cinous adenocarcinoma, histological diagnosis was de-
termined by morphological features of the tumor.
Fig. 1 Computed tomography scan of the thorax with coronal view
demonstrating of reticular interstitial opacities
Fig. 2 Computed tomography scan of the thorax with axial view
demonstrating of reticular interstitial opacities with plenty of thick
mucus, and thickening of interlobular septa
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There were no detected mutations in EGFR gene.
KRAS wild type genotype was detected on codons 12
and 13. Biopsy tissue didn’t show signs of pulmonary
fibrosis. Seven days later, the patient died presenting
terminal respiratory failure.
Conclusion
Given the fact that radiography cannot always make a
clear-cut difference between pulmonary fibrosis and lung
adenocarcinomas, and that clinical symptoms often
overlap, histological examination should be considered
as gold standard for diagnosis of lung adenocarcinoma.
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Fig. 4 Close-up view of mucinous adenocarcinoma of the lung
whose pattern was largely lepidic with smaller foci acinar growth
Fig. 3 Tissue histology revealed mucinous adenocarcinoma of the
lung whose pattern was largely lepidic with smaller foci
acinar growth
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